company background image
ERIS logo

Eris Lifesciences NSEI:ERIS 주식 보고서

최종 가격

₹1.35k

시가총액

₹183.4b

7D

4.3%

1Y

54.3%

업데이트

01 Nov, 2024

데이터

회사 재무 +

Eris Lifesciences Limited

NSEI:ERIS 주식 보고서

시가총액: ₹183.4b

ERIS 주식 개요

에리스 라이프사이언스는 자회사와 함께 인도에서 만성 및 아만성 치료제를 위한 국내 브랜드 제제를 제공합니다.

ERIS 기본 분석
눈송이 점수
가치 평가1/6
미래 성장4/6
과거 실적2/6
재무 상태3/6
배당금0/6

Eris Lifesciences Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Eris Lifesciences
과거 주가
현재 주가₹1,347.15
52주 최고치₹1,522.05
52주 최저치₹809.15
베타0.31
11개월 변경1.73%
3개월 변경 사항20.17%
1년 변경 사항54.31%
33년 변화65.23%
5년 변화223.45%
IPO 이후 변화123.97%

최근 뉴스 및 업데이트

Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

Oct 30
Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Oct 15
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Sep 19
Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Recent updates

Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

Oct 30
Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Oct 15
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Sep 19
Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Sep 03
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Aug 05
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Aug 04
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Jul 13
Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

May 24
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

May 10
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Mar 14
An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Feb 15
Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Dec 28
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Dec 07
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Nov 11
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Jul 20
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

Nov 20
Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

Jun 20
These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Feb 24
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Dec 28
Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

Sep 23
Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

May 26
If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 17
Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Mar 12
Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Feb 25
Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Feb 12
Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Jan 30
Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Jan 17
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Dec 30
Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 10
Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

주주 수익률

ERISIN PharmaceuticalsIN 마켓
7D4.3%2.6%2.3%
1Y54.3%59.1%37.9%

수익률 대 산업: ERIS 지난 1년 동안 59.1 %를 반환한 Indian Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: ERIS 지난 1년 동안 37.9 %를 반환한 Indian 시장을 초과했습니다.

가격 변동성

Is ERIS's price volatile compared to industry and market?
ERIS volatility
ERIS Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.1%

안정적인 주가: ERIS 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: ERIS 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
20073,620Amit Bakshiwww.eris.co.in

에리스 라이프사이언스는 자회사와 함께 인도에서 만성 및 준만성 치료를 위한 국내 브랜드 제제를 제공합니다. 이 회사는 항당뇨, 심혈관, 영양, 피부과, 신경과학, 산부인과, 신장내과, 종양학은 물론 중추신경계, 여성 건강, 비타민/미네랄/영양소 등 다양한 치료 영역에서 다양한 브랜드 제형을 제공합니다. 또한 외래 혈압 측정, 외래 심전도 측정, 연속 혈당 모니터링 시스템, 수면 연구, 산전 관리 솔루션 등 환자 관리 서비스도 제공합니다.

Eris Lifesciences Limited 기본 사항 요약

Eris Lifesciences 의 수익과 매출은 시가총액과 어떻게 비교하나요?
ERIS 기본 통계
시가총액₹183.35b
수익(TTM)₹3.48b
수익(TTM)₹24.85b

52.6x

P/E 비율

7.4x

P/S 비율

ERIS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
ERIS 손익 계산서(TTM)
수익₹24.85b
수익 비용₹5.90b
총 이익₹18.95b
기타 비용₹15.47b
수익₹3.48b

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)25.60
총 마진76.25%
순이익 마진14.02%
부채/자본 비율84.8%

ERIS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기